Full Press Release Details
Knezovich N, Thiel JK, Lizama BN, et al. Sigma-2 receptor modulators including CT1812 modulate low density lipoprotein uptake in primary rat neurons . Poster presented at Keystone 2025 ; Whistler, BC, Canada
CGTX Positive Sentiment
Sigma-2 receptor modulators including CT1812 modulate low density lipoprotein uptake in primary rat neurons
Key Takeaway: The research presented by Knezovich et al. at Keystone 2025 highlights the role of sigma-2 receptor modulators, particularly CT1812, in influencing low-density lipoprotein uptake in primary rat neurons. This study may have implications for understanding lipid metabolism in neurological contexts.
Price reaction · baseline $0.316 (2025-06-11T14:42:00.000Z) · hit during market hours · clean, no other CGTX news in the window
day 0 close · peak
+0.4%
Market Sentiment Analysis
POSITIVE FACTORS
- CT1812 shows potential in modulating lipid uptake.
- Research presented at a notable conference.
- Focus on primary rat neurons indicates relevance to neurobiology.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+35%
120-day peak, hindsight
Typical move
8.3%
average across 6 past catalysts
Cash runway
~33 mo
Minimal dilution risk
Lead asset
Oxytocin
Phase 2 · Oxidative Stress
Frequently Asked Questions
What is the focus of the research on CT1812?
The research focuses on how CT1812 modulates low-density lipoprotein uptake in primary rat neurons.
Where was the research on CT1812 presented?
The research was presented at the Keystone 2025 conference in Whistler, BC, Canada.
What are sigma-2 receptor modulators?
Sigma-2 receptor modulators are compounds that interact with sigma-2 receptors, influencing various biological processes.
Why is low-density lipoprotein uptake important?
Low-density lipoprotein uptake is crucial for understanding lipid metabolism, especially in neurological contexts.